Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Harold J. Burstein(Dana-Farber Cancer Institute), Jennifer J. Griggs(Michigan Medicine), Nancy E. Davidson(WinnMed), Thomas A. Buchholz(Scripps MD Anderson Cancer Center), Clifford A. Hudis(American Society of Clinical Oncology), Diana Rowden(BC Cancer Agency), Vered Stearns(Johns Hopkins University), Karen Gelmon(BC Cancer Agency), Eric P. Winer(University of Vermont), Sarah Temin(Virginia Cancer Institute), Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Alexander J. Solky(BC Cancer Agency), Holly Anderson(BC Cancer Agency)
Cited by 795
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k